ChemicalBook > CAS DataBase List > Naxitamab
Naxitamab
- Product Name
- Naxitamab
- CAS No.
- 1879925-92-4
- Chemical Name
- Naxitamab
- Synonyms
- Naxitamab;Naxitamab (anti-GD2);Research Grade Naxitamab;Research Grade Naxitamab(DGK07803);Naxitamab-gqgk|||Humanized 3F8|||Hu3F8
- CBNumber
- CB38081123
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Naxitamab Property
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Naxitamab Chemical Properties,Usage,Production
Uses
Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers[1].
in vivo
Naxitamab (Hu3F8; 100 mg/kg; i.v.; twice a week, for 4 weeks; athymic nude mice with LAN-1 xenografts) inhibits tumor growth in neuroblastoma xenografts[1].
| Animal Model: | Female athymic nude mice with LAN-1 xenografts[1] |
| Dosage: | 100 mg/kg |
| Administration: | Intravenous injection; twice a week, for 4 weeks |
| Result: | Inhibited tumor growth and prolonged the survival time. |
References
[1] Cheung NK, et, al. Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo. Oncoimmunology. 2012 Jul 1;1(4):477-486. DOI:10.4161/onci.19864
[2] Markham A. Naxitamab: First Approval. Drugs. 2021 Feb;81(2):291-296. DOI:10.1007/s40265-021-01467-4
Naxitamab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Naxitamab Suppliers
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32435
- Advantage
- 58
- Tel
- tp@aladdinsci.com
- Country
- United States
- ProdList
- 57505
- Advantage
- 58
1879925-92-4, NaxitamabRelated Search:
Pembrolizumab
Research Grade Tacatuzumab (DHC01501)
Muromonab-CD3
Serclutamab
Brontictuzumab
Foralumab
Rolinsatamab
Rozanolixizumab
Ontuxizumab
Mupadolimab